← Leaderboards
Carlos F Barbas
Scripps Research Institute
$17,256,782
Attributed
$17,256,782
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2005–13$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$17,256,782 · 13
By mechanism
R01$12,594,836 · 8
DP1$3,741,315 · 2
R21$920,631 · 2
P01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute
Same institution · by research overlap
- Kim D Janda$47,128,009
- Chi-Huey Wong$11,823,568
- Richard A Lerner$0
- Gerald F Joyce$4,317,222
- Subhash C Sinha$3,568,854
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseTranscription FactorNovel StrategiesAngiogenesisGene TherapySiteGene Induction /RepressionDesignHiv-1CellsAntibodiesLaboratory RabbitT-LymphocyteMutationEngineeringSpecificityHuman TissueGene TargetingProgramsCancer TherapyGrowth Factor ReceptorsProtein EngineeringChimeric ProteinsProtein Structure
Grant awards (46)
Chemically Programmed Immunity$911,805
DP1 · FY2013 · CA · contact PI
Multifunctional Human Anti-HIV Antibodies$445,325
R01 · FY2013 · AI · contact PI
Chemically Programmed Immunity$940,005
DP1 · FY2012 · CA · contact PI
Multifunctional Human Anti-HIV Antibodies$473,750
R01 · FY2012 · AI · contact PI
Chemically Programmed Immunity$940,005
DP1 · FY2011 · OD · contact PI
Multifunctional Human Anti-HIV Antibodies$473,750
R01 · FY2011 · AI · contact PI
Chemically Programmed Immunity$949,500
DP1 · FY2010 · OD · contact PI
Transcriptional Blockades of HIV-1$398,660
R01 · FY2010 · GM · contact PI
Chemically Programmed Antibodies for Cancer Therapy$310,063
R01 · FY2010 · CA · contact PI
Transcriptional Blockades of HIV-1$402,687
R01 · FY2009 · GM · contact PI
Chemically Programmed Antibodies for Cancer Therapy$310,063
R01 · FY2009 · CA · contact PI
Zinc Finger Recombinases for Endogenous Genome Tailoring$251,641
R21 · FY2009 · CA · contact PI
Transcriptional Blockades of HIV-1$402,687
R01 · FY2008 · GM · contact PI
Chemically Programmed Antibodies for Cancer Therapy$294,676
R01 · FY2008 · CA · contact PI
Zinc Finger Recombinases for Endogenous Genome Tailoring$209,700
R21 · FY2008 · CA · contact PI
Transcriptional Blockades of HIV-1$396,100
R01 · FY2007 · GM · contact PI
Chemically Programmed Antibodies for Cancer Therapy$291,877
R01 · FY2007 · CA · contact PI
Gene transfer of antibodies targeting tumor angiogenesis$321,909
R01 · FY2006 · CA · contact PI
Chemically Programmed Antibodies for Cancer Therapy$300,594
R01 · FY2006 · CA · contact PI
Transcriptional Blockades of HIV-1$293,262
R01 · FY2006 · GM · contact PI
A Selective Approach to Metastatic Gene Discovery$226,915
R21 · FY2006 · GM · contact PI
Gene transfer of antibodies targeting tumor angiogenesis$329,656
R01 · FY2005 · CA
Chemically Programmed Antibodies for Cancer Therapy$307,828
R01 · FY2005 · CA
Transcriptional Blockades of HIV-1$300,320
R01 · FY2005 · GM
A Selective Approach to Metastatic Gene Discovery$232,375
R21 · FY2005 · GM
Targeted Activation of Fetal Hemoglobin$441,700
R01 · FY2004 · DK
ENDOGENOUS GENE REGULATION FOR CANCER AND ANGIOGENESIS$362,529
R01 · FY2004 · CA
Gene transfer of antibodies targeting tumor angiogenesis$329,656
R01 · FY2004 · CA
Chemically Programmed Antibodies for Cancer Therapy$307,828
R01 · FY2004 · CA
Transcriptional Blockades of HIV-1$300,320
R01 · FY2004 · GM
Targeted Activation of Fetal Hemoglobin$441,700
R01 · FY2003 · DK
ENDOGENOUS GENE REGULATION FOR CANCER AND ANGIOGENESIS$362,529
R01 · FY2003 · CA
Gene transfer of antibodies targeting tumor angiogenesis$329,656
R01 · FY2003 · CA
Transcriptional Blockades of HIV-1$300,320
R01 · FY2003 · GM
Targeted Activation of Fetal Hemoglobin$441,700
R01 · FY2002 · DK
IN VITRO EVOLUTION OF HUMAN ANTIHIV ANTIBODIES$364,935
R01 · FY2002 · AI
ENDOGENOUS GENE REGULATION FOR CANCER AND ANGIOGENESIS$362,529
R01 · FY2002 · CA
IN VITRO SELECTION OF CATALYTIC ANTIBODIES$0
P01 · FY2002 · CA
Targeted Activation of Fetal Hemoglobin$428,834
R01 · FY2001 · DK
IN VITRO EVOLUTION OF HUMAN ANTIHIV ANTIBODIES$354,305
R01 · FY2001 · AI
ENDOGENOUS GENE REGULATION FOR CANCER AND ANGIOGENESIS$347,065
R01 · FY2001 · CA
IN VITRO SELECTION OF CATALYTIC ANTIBODIES$0
P01 · FY2001 · CA
CHEMOKINE RECEPTOR ANTAGONISTS FOR HIV1 THERAPY$374,971
R01 · FY2000 · AI
ENDOGENOUS GENE REGULATION FOR CANCER AND ANGIOGENESIS$347,065
R01 · FY2000 · CA
IN VITRO EVOLUTION OF HUMAN ANTIHIV ANTIBODIES$343,987
R01 · FY2000 · AI
IN VITRO SELECTION OF CATALYTIC ANTIBODIES$0
P01 · FY2000 · CA